Literature DB >> 22077669

Excisional biopsy for management of lateral tongue leukoplakia.

Woo-Jin Jeong1, Jin Ho Paik, Sung-Woo Cho, Myung-Whun Sung, Kwang Hyun Kim, Soon-Hyun Ahn.   

Abstract

BACKGROUND: Leukoplakia of the lateral tongue is frequently associated with the risk of malignancy. Although incisional biopsy is accepted as a standard technique for evaluation, the possibility of underdiagnosis, and therefore missed diagnosis of malignancy, remains at all times. The aim of this study was to determine the rate of underdiagnosis by incisional biopsy for leukoplakia of the lateral tongue and to elucidate the underlying cause of for underdiagnosis.
METHODS: Twenty-two patients with leukoplakia in the lateral tongue who had undergone excisional biopsy for suspicion of malignancy were included in the study. Pathology was reviewed and classified into 'no dysplasia,''dysplasia,' and 'carcinoma'. Underdiagnosis was defined as a change of diagnosis to a graver classification following excisional biopsy. To analyze the factors contributing to underdiagnosis, incisional and excisional biopsy specimens were re-evaluated.
RESULTS: Of the 22 patients with leukoplakia of the lateral tongue, 59.1% had coexistent malignancy, including nine squamous cell carcinomas and four verrucous carcinomas. Incisional biopsy resulted in underdiagnosis in 73.3% of the cases. Underdiagnosis was attributable to three common errors, which were mis-selection of sampling site within a large area of leukoplakia, error in pathology specimen preparation owing to small specimen size, and superficial biopsy frequently associated with punch biopsy.
CONCLUSION: Leukoplakia of the lateral tongue is highly coexistent with malignancy, and incisional biopsy frequently leads to underdiagnosis. Therefore, complete excision with adequate margin is warranted for leukoplakia of the lateral tongue, preferably under general anesthesia, which could be performed with minimal morbidity and function preservation.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 22077669     DOI: 10.1111/j.1600-0714.2011.01106.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

1.  Er,Cr:YSGG laser therapy for oral leukoplakia minimizes thermal artifacts on surgical margins: a pilot study.

Authors:  J Seoane; A González-Mosquera; J López-Niño; L García-Caballero; C Aliste; J M Seoane-Romero; P Varela-Centelles
Journal:  Lasers Med Sci       Date:  2013-01-17       Impact factor: 3.161

2.  Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.

Authors:  Shih-Wei Yang; Yun-Shien Lee; Liang-Che Chang; Cheng-Han Yang; Cheng-Ming Luo; Pei-Wen Wu
Journal:  Clin Oral Investig       Date:  2021-01-07       Impact factor: 3.573

3.  Oral cancer development in patients with leukoplakia--clinicopathological factors affecting outcome.

Authors:  Wei Liu; Lin-Jun Shi; Lan Wu; Jin-Qiu Feng; Xi Yang; Jiang Li; Zeng-Tong Zhou; Chen-Ping Zhang
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

4.  Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.

Authors:  Song Dong; Ning Zhao; Wei Deng; Hui-Wen Sun; Fei-Yu Niu; Jin-Ji Yang; Wen-Zhao Zhong; Feng Li; Hong-Hong Yan; Chong-Rui Xu; Qiu-Yi Zhang; Xue-Ning Yang; Ri-Qiang Liao; Qiang Nie; Yi-Long Wu
Journal:  World J Surg Oncol       Date:  2017-01-09       Impact factor: 2.754

5.  Prospective evaluation of oral premalignant lesions using a multimodal imaging system: a pilot study.

Authors:  Eric C Yang; Imran S Vohra; Hawraa Badaoui; Richard A Schwarz; Katelin D Cherry; Justin Jacob; Jessica Rodriguez; Michelle D Williams; Nadarajah Vigneswaran; Ann M Gillenwater; Rebecca R Richards-Kortum
Journal:  Head Neck       Date:  2019-10-17       Impact factor: 3.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.